FDA denies soft line on violation, issues White Paper
This article was originally published in Clinica
Republicans in the White House usually signal a more business-friendly regulatory system. But the FDA denies it is soft on industry. On the contrary, the agency issued a "White Paper" this week to show it is pursuing an aggressive reinforcement strategy.